Home Cart 0 Sign in  

[ CAS No. 501-13-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 501-13-3
Chemical Structure| 501-13-3
Structure of 501-13-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 501-13-3 ]

Related Doc. of [ 501-13-3 ]

Alternatived Products of [ 501-13-3 ]

Product Details of [ 501-13-3 ]

CAS No. :501-13-3 MDL No. :MFCD01736565
Formula : C14H20N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :SFUVCMKSYKHYLD-FNORWQNLSA-N
M.W : 264.32 Pubchem ID :5281796
Synonyms :

Calculated chemistry of [ 501-13-3 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 8
Num. H-bond acceptors : 4.0
Num. H-bond donors : 3.0
Molar Refractivity : 74.79
TPSA : 84.58 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.37
Log Po/w (XLOGP3) : 1.03
Log Po/w (WLOGP) : 1.16
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 1.82
Consensus Log Po/w : 1.45

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.83
Solubility : 3.88 mg/ml ; 0.0147 mol/l
Class : Very soluble
Log S (Ali) : -2.4
Solubility : 1.06 mg/ml ; 0.00402 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.3
Solubility : 0.132 mg/ml ; 0.000498 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.4

Safety of [ 501-13-3 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P273-P280-P305+P351+P338 UN#:3077
Hazard Statements:H315-H318-H335-H400 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 501-13-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 501-13-3 ]

[ 501-13-3 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1135-24-6 ]
  • [ 110-60-1 ]
  • [ 501-13-3 ]
YieldReaction ConditionsOperation in experiment
20% Stage #1: 3-(4-hydroxy-3-methoxyphenyl)acrylic acid With dicyclohexyl-carbodiimide In acetone at 20℃; for 1h; Darkness; Stage #2: 1,4-diaminobutane With Sodium hydrogenocarbonate In acetone at 20℃; for 24h; Darkness; 3.2. General Procedure for the Synthesis of Compounds 1-8 General procedure: All protocols used for optimization of the synthesis are given in the supplementary information (Table S1). This section focusses on the optimized final protocol. To a 0.072 M solution of N,N′-dicyclohexylcarbodiimide (DCC) in acetone, an equimolar amount of hydroxycinnamic acid was added. The solution was stirred for 1 h at room temperature in the dark. Photoisomerization has been reported for several phenol amides,[23,24] therefore exposure to light was limited as much as possible during all syntheses. After 1 h an equimolar amount of the desired amine was added, followed by addition of a 0.072 M sodium bicarbonate solution in a volume equal to the starting volume of acetone. The mixture was stirred for 24 h at room temperature and in the dark. After 24 h the reaction was stopped by adding an equimolar amount of acetic acid. Insoluble N,N′- dicyclohexylurea (DCU) formed was removed by filtration using a cellulose filter. A sample of 200 μL was taken and centrifuged (10,000× g, 5 min) prior to analysis by UHPLCPDA-ESI-IT-MS. For the remaining reaction mixture, acetone was removed under reduced pressure at 40 °C after which the remaining water phase was washed three times with ethyl acetate. For further purification by flash chromatography, the ethyl acetate fraction was used for phenol amides with anthranilate, serotonin, tyramine, and tryptamine subunits. For phenol amides with agmatine or putrescine subunits, the water fraction was used. To the ethyl acetate samples 5 mL water was added prior to concentration. All samples were concentrated under reduced pressure at 60 °C to remove the ethyl acetate before purification by flash chromatography.
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 501-13-3 ]

Aryls

Chemical Structure| 103188-46-1

[ 103188-46-1 ]

(E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide

Similarity: 0.89

Chemical Structure| 20069-09-4

[ 20069-09-4 ]

(E)-1-(3-(3,4,5-Trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 3400-22-4

[ 3400-22-4 ]

4-Methoxy-N-methylbenzamide

Similarity: 0.79

Chemical Structure| 456-12-2

[ 456-12-2 ]

N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide

Similarity: 0.79

Chemical Structure| 17061-63-1

[ 17061-63-1 ]

N-(4-Methoxybenzyl)formamide

Similarity: 0.76

Alkenes

Chemical Structure| 103188-46-1

[ 103188-46-1 ]

(E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide

Similarity: 0.89

Chemical Structure| 94-62-2

[ 94-62-2 ]

(2E,4E)-5-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

Similarity: 0.84

Chemical Structure| 20069-09-4

[ 20069-09-4 ]

(E)-1-(3-(3,4,5-Trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 456-12-2

[ 456-12-2 ]

N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide

Similarity: 0.79

Chemical Structure| 127033-74-3

[ 127033-74-3 ]

N-(3-Methoxyphenyl)cinnamamide

Similarity: 0.74

Ethers

Chemical Structure| 59084-72-9

[ 59084-72-9 ]

5,6-Dimethoxyisoindolin-1-one

Similarity: 0.85

Chemical Structure| 20069-09-4

[ 20069-09-4 ]

(E)-1-(3-(3,4,5-Trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 22246-04-4

[ 22246-04-4 ]

7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one

Similarity: 0.82

Chemical Structure| 22246-12-4

[ 22246-12-4 ]

6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one

Similarity: 0.82

Chemical Structure| 132680-54-7

[ 132680-54-7 ]

6-Methoxyisoindolin-1-one

Similarity: 0.81

Amides

Chemical Structure| 103188-46-1

[ 103188-46-1 ]

(E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide

Similarity: 0.89

Chemical Structure| 59084-72-9

[ 59084-72-9 ]

5,6-Dimethoxyisoindolin-1-one

Similarity: 0.85

Chemical Structure| 94-62-2

[ 94-62-2 ]

(2E,4E)-5-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

Similarity: 0.84

Chemical Structure| 20069-09-4

[ 20069-09-4 ]

(E)-1-(3-(3,4,5-Trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one

Similarity: 0.82

Chemical Structure| 22246-12-4

[ 22246-12-4 ]

6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one

Similarity: 0.82

Amines

Chemical Structure| 103188-46-1

[ 103188-46-1 ]

(E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide

Similarity: 0.89

Chemical Structure| 3400-22-4

[ 3400-22-4 ]

4-Methoxy-N-methylbenzamide

Similarity: 0.79

Chemical Structure| 456-12-2

[ 456-12-2 ]

N-(2-Hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide

Similarity: 0.79

Chemical Structure| 1202-66-0

[ 1202-66-0 ]

N-(4-Hydroxyphenethyl)acetamide

Similarity: 0.76

Chemical Structure| 17061-63-1

[ 17061-63-1 ]

N-(4-Methoxybenzyl)formamide

Similarity: 0.76